TCMBANKIN004045 |
ophthalmicacid |
|
C11H19N3O6 |
289.29 g/mol |
CCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N |
TCMBANKIN004074 |
3-(2-thienyl)propargyl aldehyde |
|
C7H4OS |
|
C1=CSC(=C1)C#CC=O |
TCMBANKIN007198 |
fugapavine |
|
C18H17NO3 |
295.3 g/mol |
CN1CCC2=CC3=C(C4=C2C1CC45C=CC(=O)C=C5)OCO3 |
TCMBANKIN021134 |
vitamin b15 |
|
C20H40N2O8 |
436.5 g/mol |
CC(C)N(C(C)C)C(C(=O)OCC(C(C(C(C(=O)O)O)O)O)O)N(C(C)C)C(C)C |
TCMBANKIN028735 |
vitamin b12 |
|
C63H88CoN14O14P |
1355.4 g/mol |
CC1=CC2=C(C=C1C)N(C=N2)C3C(C(C(O3)CO)OP(=O)([O-])OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=C(C7=NC(=CC8=NC(=C(C4=N5)C)C(C8(C)C)CCC(=O)N)C(C7(C)CC(=O)N)CCC(=O)N)C)[N-]6)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[C-]#N.[Co+3] |
TCMBANKIN029165 |
1,4-thiazane-3-carboxylicacid s-oxide |
|
C5H9NO3S |
|
C1CS(=O)CC(N1)C(=O)O |
TCMBANKIN039311 |
Sarisan |
NSC44848; Benzene, 1-allyl-2-methoxy-4,5-methylenedioxy; C10493; 5-methoxy-6-prop-2-enyl-1,3-benzodioxole; sarisan; NSC 27868; NSC27868; 1,3-Benzodioxole, 5-methoxy-6-(2-propenyl)-; AI3-31217; 5-allyl-6-methoxy-1,3-benzodioxole; 18607-93-7; 1-Allyl-2-methoxy-4,5-(methylenedioxy)benzene |
C11H12O3 |
192.211 |
c1([H])c(C([H])([H])C([H])=C([H])[H])c(OC([H])([H])[H])c([H])c(OC([H])([H])O2)c12 |
TCMBANKIN044494 |
isololiolide |
|
C11H16O3 |
196.24 g/mol |
CC1(CC(CC2(C1=CC(=O)O2)C)O)C |
TCMBANKIN045496 |
phytolaccoside b |
|
C36H56O11 |
664.8 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)OC6C(C(C(CO6)O)O)O)O)C)C)C2C1)C)C(=O)O)C(=O)OC |
TCMBANKIN046015 |
saringosterol |
Saringosterol; 24-vinyl-cholest-5-ene-3beta,24-diol; LMST01040167; CHEMBL252366 |
C29H48O2 |
429 |
C1([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@](O[H])(C([
H])=C([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C4([H])[H])[C@@]34[H])C([H])([H])[C@@]1([H])O[H] |
TCMBANKIN046968 |
fritillaziebinol |
Fritillaziebinol |
ClO |
324.98 |
CC1(CCCC2(C1CCC34C2CCC(C3)C(C4)(CCl)O)C)C |
TCMBANKIN049148 |
beta-ionone |
(E)-4-(2,6,6-trimethyl-1-cyclohexenyl)but-3-en-2-one; (Z)-4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-3-buten-2-one; BB_NC-0321; 4-(2,6,6-Trimethylcyclohex-1-ene-1-yl)-but-3-ene-2-one; NSC 402758; beta-Cyclocitrylideneacetone; SCHEMBL813343; AIDS-032326; AIDS032326; EINECS 238-969-9; 4-(2,6,6-trimethyl-1-cyclohexenyl)but-3-en-2-one; .beta.-Cyclocitrylideneacetone; 4-(2,6,6-Trimethyl-1-cyclohexenyl)-3-buten-2-one; W259500_ALDRICH; 4-(2,6,6-Trimethyl-1-cyclohexen-l-yl)-3-buten-2-one; NSC46137; WLN: L6UTJ A1U1V1 B1 F1 F1; e-4-(2,6,6-trimethyl-cyclohexyl)-but-3-en-2-one; LS-871; EINECS 252-325-4; YJRODKCOICMRBO-BQYQJAHWSA-N; LS-47337; 35031-06-2; ST5306954; trans-.beta.-Ionone; 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (E); IONONE, BETA; EINECS 252-912-5; β- Ionone; 58180_FLUKA; (3E)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)but-3-en-2-one; 4-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-3-buten-2-one; .beta.-Ionone isomer # 1; C12287; NSC402758; (3E)-4-(2,2,6-TRIMETHYLCYCLOHEXYL)BUT-3-EN-2-ONE; 14901-07-6; 4-(2,6,6-Trimethyl-2(1)-cyclohexen-1-yl)-3-buten-2-one; .beta.-Ionone isomer # 2; SCHEMBL813341; Dihydroionone; ZINC03881456; AC1O5BV0; Ionone, .beta.-; 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (3E)-; CCRIS 6249; (E)-4-(2,2,6-trimethylcyclohexyl)but-3-en-2-one; 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-, (E)-; I12603_ALDRICH; InChI=1/C13H20O/c1-10-6-5-9-13(3,4)12(10)8-7-11(2)14/h7-8H,5-6,9H2,1-4H3/b8-7; β-ionone; W259519_ALDRICH; .beta.-Ionone; beta-Ionone; 79-77-6; 3-Buten-2-one, 4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-; .beta.-Ionene; 4-(2,2,6-Trimethylcyclohexyl)-3-buten-2-one; 36208-32-9 |
C13H20O |
192.297 |
C1([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C(\C([H])=C([H])\C(=O)C([H])([H])[H])=C(C([H])([H])[H])C([H])([H])C1([H])[H] |
TCMBANKIN059064 |
noropthalmicacid |
|
C10H17N3O6 |
|
CC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N |
TCMBANKIN059403 |
Fucosterol |
|
C29H48O |
412.7 g/mol |
CC=C(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
TCMBANKIN059611 |
esculentoside B |
|
C36H56O11 |
664.8 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)OC6C(C(C(CO6)O)O)O)O)C)C)C2C1)C)C(=O)O)C(=O)OC |
TCMBANKIN060140 |
friedelan-3-one |
|
C30H50O |
426.7 g/mol |
CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC5(C4CC(CC5)(C)C)C)C)C)C)C |
TCMBANKIN061358 |
fugapavine |
(-)-mecambrin |
C18H17NO3 |
295.3 g/mol |
CN1CCC2=CC3=C(C4=C2C1CC45C=CC(=O)C=C5)OCO3 |
TCMBANKIN061374 |
n'-methyl nicotineamide |
n'-methylnicotineamide |
C7H8N2O |
|
CNC(=O)C1=CN=CC=C1 |
TCMBANKIN061461 |
kumujian d |
methylnigakinone;methyl nigakinone |
C16H12N2O3 |
280.28 g/mol |
COC1=C(C(=O)N2C3=CC=CC=C3C4=C2C1=NC=C4)OC |